iXensor Co., Ltd. (6734.TWO)

TWD 3.95

(-4.59%)

Market Cap (In TWD)

120.96 Million

Revenue (In TWD)

20.88 Million

Net Income (In TWD)

-63.19 Million

Avg. Volume

44.14 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.86-22.2
PE
-
EPS
-
Beta Value
0.43
ISIN
TW0006734007
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
Dr. Carson Chen Ph.D.
Employee Count
-
Website
https://www.ixensor.com
Ipo Date
2019-06-28
Details
iXensor Co., Ltd. provides technology platform that turns smartphones into in vitro diagnostic devices through its smart color sensing technology for connected healthcare. The company's PixoTest technology uses the lighting and image sensing module of the smartphone to detect the color change reaction on the immunoassay or colorimetric strip. It offers PixoTest Blood Glucose Monitoring System and PixoTest POCT System for chronic diseases management; Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management; and PixoTest COVID-19 Rapid Antigen Test for infectious disease management, as well as PixoHealth Pass Admin app and Web portal. The company was founded in 2012 and is based in Taipei, Taiwan.